• LINC01278 Drives Autophagy to Suppress Uveal Melanoma via mT

  2026-07-30

  This study identifies the long noncoding RNA LINC01278 as a novel autophagy inducer and tumor suppressor in uveal melanoma, acting through inhibition of the mTOR signaling pathway. These findings highlight the translational value of targeting autophagy pathways in cancer research and provide a mechanistic framework for future studies using autophagy modulators such as 3-Methyladenine.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor Workflows Unv

  2026-07-30

  7ACC2 empowers cancer metabolism research with dual MCT1 and mitochondrial pyruvate transport inhibition, enabling precise control of lactate flux in tumor studies. This guide delivers actionable protocols, troubleshooting strategies, and connects recent immunometabolic advances to experimental practice.

• SB743921: Applied Protocols for Kinesin Spindle Protein Inhi

  2026-07-29

  SB743921 enables precise, reproducible cell cycle arrest and apoptosis in cancer research, thanks to its nanomolar potency and selectivity for KSP. This guide translates bench research into actionable protocols, advanced troubleshooting, and comparative insights for maximizing anti-proliferative assay performance.

• Dasatinib (BMS-354825): Precision Kinase Inhibition in Cance

  2026-07-29

  Dasatinib (BMS-354825) empowers researchers to dissect Src and Bcr-Abl signaling in cancer models with nanomolar precision. This article delivers actionable workflow enhancements, troubleshooting strategies, and translational insights for applied oncology research.

• MEK1/2 and c-Myc-Max Cooperate to Regulate TERT in Stem Cell

  2026-07-28

  This study reveals how MEK1/2 kinases and the c-Myc-Max complex coordinate to prevent polycomb-mediated repression of the TERT gene in human pluripotent stem cells. The findings clarify chromatin-based mechanisms controlling telomerase expression, advancing our understanding of stem cell self-renewal and telomere maintenance.

• Macrophage EVs-miR-660 Drives Breast Cancer Metastasis via K

  2026-07-28

  This study uncovers a tumor-promoting mechanism in breast cancer, where macrophage-derived extracellular vesicles deliver microRNA-660 to cancer cells, suppressing KLHL21 and activating the NF-κB pathway. These findings inform new directions for targeting metastatic disease by disrupting microRNA-mediated cancer–immune cell communication.

• D-Luciferin: Enhancing Firefly Luciferase Assays in Immuno-O

  2026-07-27

  D-Luciferin, as a high-affinity firefly luciferase substrate, enables non-invasive bioluminescence imaging, sensitive ATP quantification, and dynamic monitoring of gene expression in live tumor models. Recent breakthroughs in immuno-oncology leverage D-Luciferin’s precision to unravel immune evasion and therapeutic response, offering practical workflow upgrades for translational research.

• Tp47-Induced Macrophage Senescence via PKM2: Mechanistic Ins

  2026-07-27

  This study reveals that Treponema pallidum protein Tp47 induces inflammatory senescence in macrophages through PKM2-mediated metabolic reprogramming. The findings illuminate a novel immune evasion strategy in syphilis and provide experimental grounds for metabolic intervention in infection-driven cellular senescence.

• Deferasirox: Advancing Iron Chelation in Ferroptosis-Targete

  2026-07-26

  Explore how Deferasirox, a leading oral iron chelator, uniquely enables advanced ferroptosis research and therapeutic innovation in oncology. This article dissects molecular mechanisms, assay design, and translational impact, offering deeper insights than previous reviews.

• β-Elemene as a Metabolic and Neuroprotection Research Tool

  2026-07-25

  β-Elemene (Levo-β-elemene) empowers precise modulation of adipogenesis and neuroprotective signaling in bench workflows, especially via AMPK and PI3K/AKT/mTOR pathways. This guide translates the latest experimental evidence and protocol innovations into actionable steps for metabolic, inflammatory, and neural assays.

• Deferasirox Fe3+ Chelate: Iron Chelation and Lysosomal Regul

  2026-07-24

  Explore Deferasirox Fe3+ chelate as a precision iron chelator, uniquely positioned for research at the intersection of iron overload, autophagy, and metabolic cell death. This article delivers advanced insights linking iron chelation mechanisms to lysosomal regulation, setting it apart from existing resources.

• Toremifene in Prostate Cancer: From Mechanism to Translation

  2026-07-24

  This thought-leadership article explores the mechanistic role of Toremifene as a second-generation selective estrogen-receptor modulator (SERM) in prostate cancer research. Integrating recent advances in the TSPAN18–STIM1–TRIM32 axis and calcium signaling, it provides strategic guidance for translational researchers. The discussion positions Toremifene as a critical probe for dissecting hormone-responsive and metastatic pathways, drawing on both primary literature and advanced workflow recommendations, while highlighting APExBIO’s offering as an industry benchmark.

• Resibufogenin Blocks NLRP3 Inflammasome to Mitigate Atherosc

  2026-07-23

  This study identifies Resibufogenin as a novel inhibitor of the NLRP3 inflammasome, offering significant therapeutic promise for atherosclerosis by reducing inflammation, lipid accumulation, and macrophage-driven plaque progression in ApoE-/- mice. The findings highlight a new mechanistic avenue for targeting cardiovascular inflammation and suggest practical implications for researchers investigating low-abundance cellular targets.

• Cy5 TSA Fluorescence System Kit: Amplified Sensitivity in IH

  2026-07-23

  Unlock 100-fold greater detection sensitivity in immunohistochemistry, immunocytochemistry, and in situ hybridization with the Cy5 TSA Fluorescence System Kit. Robust horseradish peroxidase catalyzed tyramide deposition and Cy5 labeling empower researchers to visualize low-abundance targets with precision and cost efficiency.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Mechanism & Research Utility

  2026-07-22

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) is a stabilized cytokine mRNA enabling precise immune activation in mouse models. The product's N1-Methylpseudo-UTP modification and Cap 1 structure enhance translation and lower innate immunogenicity, supporting reproducible immunotherapy research and gene expression workflows.

16485 records 1/1099 page Next 12345 下5页 Last page